Speaker illustration

Doctor Olena Hetman

L.T.Malaya Institute of Therapy, Kharkiv (Ukraine)

Osteopontin as a marker of pulmonary hypertension in patients with coronary heart disease combined with chronic obstructive pulmonary disease.

Event: Frontiers in CardioVascular Biology 2016

Topic: Pulmonary hypertension

Session: Arterial and pulmonary hypertension

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb